Compare OLLI & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLLI | PTCT |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.7B |
| IPO Year | 2015 | 2006 |
| Metric | OLLI | PTCT |
|---|---|---|
| Price | $71.91 | $84.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | ★ $139.31 | $80.65 |
| AVG Volume (30 Days) | ★ 2.3M | 1.9M |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.43 | ★ 264.48 |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $2,649,198,000.00 | $264,734,000.00 |
| Revenue This Year | $15.62 | N/A |
| Revenue Next Year | $11.33 | $17.70 |
| P/E Ratio | $77.60 | ★ N/A |
| Revenue Growth | 16.62 | ★ 36.19 |
| 52 Week Low | $70.85 | $43.18 |
| 52 Week High | $141.74 | $87.50 |
| Indicator | OLLI | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 68.32 |
| Support Level | N/A | $73.41 |
| Resistance Level | $124.31 | $87.50 |
| Average True Range (ATR) | 3.69 | 3.06 |
| MACD | -0.70 | 1.01 |
| Stochastic Oscillator | 5.06 | 79.99 |
Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name-brand household items that consumers use every day at prices heavily discounted compared with traditional retailers. It offers customers a broad selection of brand-name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. The company operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun, engaging treasure-hunt shopping experience, a compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.